Skip to main content
Premium Trial:

Request an Annual Quote

Nasdaq Warns BG Medicine Again on Listing Requirement

NEW YORK (GenomeWeb News) – BG Medicine has been warned by Nasdaq that it fails to meet another requirement to remain listing on the Nasdaq Global Market, the company said in a document filed with the US Securities and Exchange Commission on Wednesday.

In a Nov. 22 letter from Nasdaq, BG Medicine was told that its publicly held shares closed below the minimum $15 million threshold for the preceding 30 consecutive business days, putting the company at risk of being delisted. BG Medicine has until May 21, 2014 to regain compliance.

The firm also is in danger of being listed from Nasdaq for failing to meet two other requirements. Earlier this month the exchange notified the company that it has not regained compliance with a listing requirement of at least $50 million in market value of its listed securities. BG Medicine has requested a hearing with a Nasdaq panel on the matter.

Additionally, BG Medicine is not in compliance with a listing requirement calling for a minimum $1 closing bid price on its stock. It has until March 24, 2014 to regain compliance with that rule.

The Scan

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.

Survey Sees Genetic Literacy on the Rise, Though Further Education Needed

Survey participants appear to have higher genetic familiarity, knowledge, and skills compared to 2013, though 'room for improvement' remains, an AJHG paper finds.

Study Reveals Molecular, Clinical Features in Colorectal Cancer Cases Involving Multiple Primary Tumors

Researchers compare mismatch repair, microsatellite instability, and tumor mutation burden patterns in synchronous multiple- or single primary colorectal cancers.

FarGen Phase One Sequences Exomes of Nearly 500 From Faroe Islands

The analysis in the European Journal of Human Genetics finds few rare variants and limited geographic structure among Faroese individuals.